Scienture Holdings, Inc. (SCNX) stock
SCNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.55−0.21 (-7.61%)
Close on Nov 18, 2026Market cap $4.56MP/E –Yield –
Scienture net income
Net income is the profit left for shareholders after every expense, interest and tax.
Scienture's net income for the twelve months ending Sep 30, 2026 was -$40.35M. For fiscal 2025 it was -$41.51M, down 557.9% from the year before. The highest annual figure on record is $9.07M in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$41.51M | -557.9% |
| FY2024 | Dec 31, 2024 | $9.07M | – |
| FY2023 | Dec 31, 2023 | -$17.84M | – |
| FY2022 | Dec 31, 2022 | -$3.47M | – |
| FY2021 | Dec 31, 2021 | -$5.32M | – |
| FY2020 | Dec 31, 2020 | -$2.54M | – |
| FY2019 | Dec 31, 2019 | -$284.43K | -3247.0% |
| FY2018 | Dec 31, 2018 | $9.04K | -96.9% |
| FY2017 | Dec 31, 2017 | $288.98K | – |
| FY2016 | Dec 31, 2016 | -$2.76M | – |
| FY2015 | Dec 31, 2015 | -$1.12M | – |
| FY2014 | Dec 31, 2014 | -$2.01M | – |
| FY2013 | Dec 31, 2013 | -$2.09M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$6.01M | – |
| Q2 FY2026 | Jun 30, 2026 | -$2.82M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.40M | – |
| Q4 FY2025 | Dec 31, 2025 | -$28.12M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.61M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.72M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.06M | -114.4% |
| Q4 FY2024 | Dec 31, 2024 | -$7.16M | – |
| Q3 FY2024 | Sep 30, 2024 | -$3.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$1.83M | – |
| Q1 FY2024 | Mar 31, 2024 | $21.25M | – |
| Q4 FY2023 | Dec 31, 2023 | -$11.67M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.53M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.97M | – |
| Q1 FY2023 | Mar 31, 2023 | -$677.95K | – |
| Q4 FY2022 | Dec 31, 2022 | -$925.19K | – |
| Q3 FY2022 | Sep 30, 2022 | -$503.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.11M | – |
| Q1 FY2022 | Mar 31, 2022 | -$965.84K | – |
| Q4 FY2021 | Dec 31, 2021 | -$784.34K | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.30M | -1040.6% |
| Q2 FY2021 | Jun 30, 2021 | -$2.58M | – |
| Q1 FY2021 | Mar 31, 2021 | -$651.52K | -461.3% |
| Q4 FY2020 | Dec 31, 2020 | -$2.31M | – |
| Q3 FY2020 | Sep 30, 2020 | $138.39K | +402.1% |
| Q2 FY2020 | Jun 30, 2020 | -$542.59K | -1035.8% |
| Q1 FY2020 | Mar 31, 2020 | $180.30K | +44.0% |
| Q4 FY2019 | Dec 31, 2019 | -$495.20K | – |
| Q3 FY2019 | Sep 30, 2019 | $27.57K | -70.8% |
| Q2 FY2019 | Jun 30, 2019 | $57.98K | +182.7% |
| Q1 FY2019 | Mar 31, 2019 | $125.23K | +52.2% |
| Q4 FY2018 | Dec 31, 2018 | -$187.99K | -234.4% |
| Q3 FY2018 | Sep 30, 2018 | $94.25K | +23.7% |
| Q2 FY2018 | Jun 30, 2018 | $20.51K | – |
| Q1 FY2018 | Mar 31, 2018 | $82.27K | +3.2% |
| Q4 FY2017 | Dec 31, 2017 | $139.91K | – |
| Q3 FY2017 | Sep 30, 2017 | $76.19K | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.84K | – |
| Q1 FY2017 | Mar 31, 2017 | $79.73K | – |
| Q4 FY2016 | Dec 31, 2016 | -$443.05K | – |
See a number that looks wrong?